References
1. Powell DW, Mifflin RC, Valentich JD, et al Paracrine cells important in health and disease. Am J Physiol 1999;277:C1–C19.
2. Powell DW, Mifflin RC, Valentich JD, et al. Myofibroblasts: II. Intestinal subepithelial myofibroblasts. Am J Physiol 1999;277:C183–C201.
3. Powell DW, Pinchuk IV, Saada JI, et al. Mesenchymal cells of the intestinal lamina propria. Annu Rev Physiol 2011;73:213–237.
4. Shao J, Sheng GG, Mifflin RC, et al. Roles of myofibroblasts in prostaglandin E2-stimulated intestinal epithelial proliferation and angiogenesis. Cancer Res 2006;66:846–855.
5. Kosinski C, Li VSW, Chan ASY, et al. Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc Natl Acad Sci USA 2007;104:15418–15423.
6. Kurokawa K, Hayakawa Y, Koike K. Plasticity of intestinal epithelium: stem cell niches and regulatory signals. Int J Mol Sci 2021;22:357–370.
7. Saada JI, Pinchuk IV, Barrera CA, et al. Subepithelial myofibroblasts are novel non-professional APCs in the human colonic mucosa. J Immunol 2006;177:5968–5979.
8. Pinchuk IV, Saada JI, Beswick EJ, et al. PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T cell activity. Gastroenterology 2008;135:1228–1237.
9. Pinchuk IV, Powell DW. Immunosuppression by intestinal stromal cells. Adv Exp Med Biol 2018;1060:115–129.
10. Barnhoorn MC, Hakuno SK, Bruckner RS, et al. Stromal cells in the pathogenesis of inflammatory bowel disease. J Crohns Colitis 2020;14: 995–1009.
11. Koliaraki V, Prados A, Armaka M, et al. The mesenchymal context in inflammation, immunity and cancer. Nat Immunol 2020;21:974–982.
12. Giraldo NA, Sanchez-Salas R, Peske JD, et al. The clinical role of the TME in solid cancer. Br J Cancer 2019;120:45–53.
13. Sahai E, Astsaturov I, Cukierman E, et al. A framework for advancing our understanding of cancer- associated fibroblasts. Nat Rev Cancer 2020;20: 174–186.
14. Roulis M, Kaklamanos A, Schernthanner M, et al. Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche. Nature 2020;580:524–529.
15. De Jaeghere EA, Denys HG, De Wever O. Fibroblasts fuel immune escape in the tumor microenvironment. Trends Cancer 2019;5:704–723.
16. Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science 2018;359:1350–1355.
17. Kennedy LC, Salama AKS. A review of cancer immunotherapy toxicity. CA Cancer J Clin 2020;70:86–104.